SIMILAR PATTERNS OF AMINO ACIDS FOR 3GGU_B_017B201

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1cu1 PROTEIN
(PROTEASE/HELICASE
NS3)


(Hepacivirus C)
PF02907
(Peptidase_S29)
PF07652
(Flavi_DEAD)
5 LEU A 365
VAL A 389
GLY A 404
ILE A 403
VAL A 408
None
1.18A 3gguA-1cu1A:
undetectable
3gguA-1cu1A:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fu1 DNA REPAIR PROTEIN
XRCC4


(Homo sapiens)
PF06632
(XRCC4)
5 LEU A 126
ALA A  42
GLY A  45
ILE A  34
VAL A 122
None
0.80A 3gguA-1fu1A:
undetectable
3gguA-1fu1A:
19.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gns SUBTILISIN BPN'

(Bacillus
amyloliquefaciens)
PF00082
(Peptidase_S8)
5 LEU A  90
GLY A  23
VAL A 121
PRO A 225
VAL A  28
None
None
None
CSO  A 221 ( 4.1A)
None
1.12A 3gguA-1gnsA:
undetectable
3gguA-1gnsA:
17.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
1.21A 3gguA-1hvcA:
13.1
3gguA-1hvcA:
39.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
1.23A 3gguA-1hvcA:
13.1
3gguA-1hvcA:
39.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 ( 4.9A)
A79  A 800 ( 4.4A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
0.38A 3gguA-1hvcA:
13.1
3gguA-1hvcA:
39.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 ( 4.7A)
A79  A 800 ( 4.3A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 ( 3.4A)
0.44A 3gguA-1hvcA:
13.1
3gguA-1hvcA:
39.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
PRO A  81
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 ( 4.9A)
A79  A 800 ( 4.4A)
A79  A 800 ( 3.7A)
A79  A 800 ( 3.9A)
0.57A 3gguA-1hvcA:
13.1
3gguA-1hvcA:
39.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1j0a 1-AMINOCYCLOPROPANE-
1-CARBOXYLATE
DEAMINASE


(Pyrococcus
horikoshii)
PF00291
(PALP)
5 LEU A  89
GLY A  47
GLY A 309
ILE A 311
VAL A  86
None
None
PLP  A 401 (-3.9A)
None
None
0.96A 3gguA-1j0aA:
undetectable
3gguA-1j0aA:
17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1l1f GLUTAMATE
DEHYDROGENASE 1


(Homo sapiens)
PF00208
(ELFV_dehydrog)
PF02812
(ELFV_dehydrog_N)
5 GLY A 192
ALA A 198
GLY A 165
ILE A 166
PRO A 169
None
1.17A 3gguA-1l1fA:
undetectable
3gguA-1l1fA:
12.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1l6w FRUCTOSE-6-PHOSPHATE
ALDOLASE 1


(Escherichia
coli)
PF00923
(TAL_FSA)
5 LEU A 149
GLY A 180
ALA A 179
ASP A 175
VAL A 146
None
1.05A 3gguA-1l6wA:
undetectable
3gguA-1l6wA:
18.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
5 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
None
0.46A 3gguA-1q9pA:
9.8
3gguA-1q9pA:
75.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1sde D-ALANYL-D-ALANINE
CARBOXYPEPTIDASE


(Streptomyces
sp. R61)
PF00144
(Beta-lactamase)
5 ARG A 287
ASP A  32
VAL A  30
GLY A 345
VAL A 319
None
1.11A 3gguA-1sdeA:
undetectable
3gguA-1sdeA:
16.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
6 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
None
1.29A 3gguA-1sivA:
19.2
3gguA-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
8 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
PRO A  81
None
0.41A 3gguA-1sivA:
19.2
3gguA-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
1.23A 3gguA-1sivA:
19.2
3gguA-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
None
0.49A 3gguA-1sivA:
19.2
3gguA-1sivA:
47.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tt4 PUTATIVE CYTOPLASMIC
PROTEIN


(Salmonella
enterica)
PF04107
(GCS2)
5 ALA A  72
ASP A  70
GLY A 255
ILE A 257
THR A  13
None
1.08A 3gguA-1tt4A:
undetectable
3gguA-1tt4A:
15.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v5j KIAA1355 PROTEIN

(Homo sapiens)
PF00041
(fn3)
5 GLY A  85
ALA A  84
VAL A  33
GLY A  60
PRO A  11
None
0.93A 3gguA-1v5jA:
undetectable
3gguA-1v5jA:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yw6 SUCCINYLGLUTAMATE
DESUCCINYLASE


(Escherichia
coli)
PF04952
(AstE_AspA)
5 ARG A 250
GLY A 180
ALA A 179
GLY A 242
ILE A 243
None
1.06A 3gguA-1yw6A:
undetectable
3gguA-1yw6A:
19.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cvj THIOREDOXIN
REDUCTASE RELATED
PROTEIN


(Thermus
thermophilus)
PF00890
(FAD_binding_2)
PF07992
(Pyr_redox_2)
6 LEU A 170
GLY A  24
ALA A  23
ASP A 177
VAL A 164
VAL A 167
None
1.00A 3gguA-2cvjA:
undetectable
3gguA-2cvjA:
19.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
7 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  55
PRO A  86
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
0.36A 3gguA-2fmbA:
15.3
3gguA-2fmbA:
32.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hlp MALATE DEHYDROGENASE

(Haloarcula
marismortui)
PF00056
(Ldh_1_N)
PF02866
(Ldh_1_C)
5 LEU A 136
ALA A  36
VAL A  26
ILE A  45
VAL A  95
None
1.08A 3gguA-2hlpA:
undetectable
3gguA-2hlpA:
15.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2isq CYSTEINE SYNTHASE

(Arabidopsis
thaliana)
PF00291
(PALP)
5 GLY A 190
ALA A 189
GLY A 183
ILE A 180
PRO A 296
None
None
PLP  A 400 (-3.4A)
PLP  A 400 (-4.9A)
PLP  A 400 (-4.0A)
0.80A 3gguA-2isqA:
undetectable
3gguA-2isqA:
16.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2j6l ALDEHYDE
DEHYDROGENASE FAMILY
7 MEMBER A1


(Homo sapiens)
PF00171
(Aldedh)
5 GLY A 231
VAL A 259
GLY A 162
ILE A 163
VAL A 255
NAI  A1501 (-3.4A)
None
None
None
None
0.92A 3gguA-2j6lA:
undetectable
3gguA-2j6lA:
11.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jg7 ANTIQUITIN

(Acanthopagrus
schlegelii)
PF00171
(Aldedh)
5 GLY A 229
VAL A 257
GLY A 160
ILE A 161
VAL A 253
NAD  A1510 (-3.4A)
None
None
None
None
0.89A 3gguA-2jg7A:
undetectable
3gguA-2jg7A:
12.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2k9x UNCHARACTERIZED
PROTEIN


(Trypanosoma
brucei)
PF09138
(Urm1)
5 LEU A  25
ASP A  91
VAL A  93
GLY A  39
VAL A   9
None
1.01A 3gguA-2k9xA:
undetectable
3gguA-2k9xA:
21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qi9 VITAMIN B12 IMPORT
SYSTEM PERMEASE
PROTEIN BTUC


(Escherichia
coli)
PF01032
(FecCD)
5 LEU A  70
GLY A 251
ALA A 250
ILE A 122
VAL A  66
None
1.15A 3gguA-2qi9A:
undetectable
3gguA-2qi9A:
14.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
LEU A  23
GLY A  27
ALA A  28
ASP A  30
GLY A  49
PRO A  81
AB1  A 501 ( 4.7A)
None
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-3.5A)
AB1  A 501 (-4.2A)
0.53A 3gguA-2rkfA:
19.9
3gguA-2rkfA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.5A)
1.16A 3gguA-2rkfA:
19.9
3gguA-2rkfA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
0.40A 3gguA-2rkfA:
19.9
3gguA-2rkfA:
76.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ada SARCOSINE OXIDASE
BETA SUBUNIT


(Corynebacterium
sp. U-96)
PF01266
(DAO)
5 LEU B 107
VAL B 272
PRO B 260
THR B 261
VAL B 263
None
0.76A 3gguA-3adaB:
undetectable
3gguA-3adaB:
14.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3cxp GLUCOSAMINE
6-PHOSPHATE
N-ACETYLTRANSFERASE


(Homo sapiens)
PF00583
(Acetyltransf_1)
5 LEU A  41
GLY A  36
VAL A  98
GLY A 130
VAL A  89
None
1.04A 3gguA-3cxpA:
undetectable
3gguA-3cxpA:
20.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3h20 REPLICATION PROTEIN
B


(Plasmid RSF1010)
PF16793
(RepB_primase)
5 LEU A 127
ALA A 133
ASP A  78
PRO A  94
VAL A  76
None
1.14A 3gguA-3h20A:
undetectable
3gguA-3h20A:
13.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i5g MYOSIN HEAVY CHAIN
ISOFORM A


(Doryteuthis
pealeii)
PF00063
(Myosin_head)
PF00612
(IQ)
PF02736
(Myosin_N)
5 LEU A 231
ALA A 339
ASP A 337
GLY A 344
VAL A 230
None
1.17A 3gguA-3i5gA:
undetectable
3gguA-3i5gA:
8.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kjk NMB1025 PROTEIN

(Neisseria
meningitidis)
PF01042
(Ribonuc_L-PSP)
5 ASP A  81
GLY A  78
ILE A  65
PRO A  90
THR A  89
None
1.14A 3gguA-3kjkA:
undetectable
3gguA-3kjkA:
19.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mud DNA REPAIR PROTEIN
XRCC4,TROPOMYOSIN
ALPHA-1 CHAIN


(Gallus gallus;
Homo sapiens)
PF06632
(XRCC4)
5 LEU A 126
ALA A  42
GLY A  45
ILE A  34
VAL A 122
None
0.78A 3gguA-3mudA:
undetectable
3gguA-3mudA:
20.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
ASP A  30
VAL A  32
GLY A  48
PRO A  81
None
0.92A 3gguA-3mwsA:
20.2
3gguA-3mwsA:
69.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
None
1.30A 3gguA-3mwsA:
20.2
3gguA-3mwsA:
69.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
PRO A  81
None
0.49A 3gguA-3mwsA:
20.2
3gguA-3mwsA:
69.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  49
ILE A  50
PRO A  81
None
0.28A 3gguA-3mwsA:
20.2
3gguA-3mwsA:
69.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nek NITROGEN
REPRESSOR-LIKE
PROTEIN MJ0159


(Methanocaldococcus
jannaschii)
PF01995
(DUF128)
5 GLY A 457
ALA A 456
GLY A 480
ILE A 376
PRO A 511
GOL  A   1 ( 4.7A)
None
None
None
None
0.98A 3gguA-3nekA:
undetectable
3gguA-3nekA:
19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3oec CARVEOL
DEHYDROGENASE
(MYTHA.01326.C,
A0R518 HOMOLOG)


(Mycolicibacterium
thermoresistibile)
PF13561
(adh_short_C2)
5 GLY A 147
ALA A 148
GLY A 122
ILE A 123
VAL A 193
None
0.94A 3gguA-3oecA:
undetectable
3gguA-3oecA:
16.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3p4g ANTIFREEZE PROTEIN

(Marinomonas
primoryensis)
no annotation 5 ASP A 103
GLY A  99
ALA A  98
VAL A 124
GLY A 137
CA  A 403 ( 2.4A)
CA  A 403 (-4.1A)
CA  A 404 (-4.5A)
None
CA  A 405 (-4.1A)
0.99A 3gguA-3p4gA:
undetectable
3gguA-3p4gA:
16.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3q4f DNA REPAIR PROTEIN
XRCC4


(Homo sapiens)
PF06632
(XRCC4)
5 LEU C 126
ALA C  42
GLY C  45
ILE C  34
VAL C 122
None
0.85A 3gguA-3q4fC:
undetectable
3gguA-3q4fC:
18.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3r0z D-SERINE DEHYDRATASE

(Salmonella
enterica)
PF00291
(PALP)
5 LEU A  20
GLY A 328
GLY A 341
PRO A 304
THR A 305
None
0.80A 3gguA-3r0zA:
undetectable
3gguA-3r0zA:
12.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slz GAG-PRO-POL
POLYPROTEIN


(Murine leukemia
virus)
PF00077
(RVP)
5 ASP A  32
GLY A  34
ALA A  35
VAL A  39
PRO A  89
3TL  A 126 (-2.4A)
3TL  A 126 (-3.1A)
3TL  A 126 ( 4.0A)
None
3TL  A 126 (-4.0A)
0.53A 3gguA-3slzA:
12.1
3gguA-3slzA:
25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slz GAG-PRO-POL
POLYPROTEIN


(Murine leukemia
virus)
PF00077
(RVP)
6 LEU A  30
ASP A  32
GLY A  34
ALA A  35
VAL A  39
GLY A  56
None
3TL  A 126 (-2.4A)
3TL  A 126 (-3.1A)
3TL  A 126 ( 4.0A)
None
3TL  A 126 (-3.4A)
0.42A 3gguA-3slzA:
12.1
3gguA-3slzA:
25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3sok FIMBRIAL PROTEIN

(Dichelobacter
nodosus)
PF00114
(Pilin)
PF07963
(N_methyl)
5 ASP A  81
GLY A  82
ASP A 124
VAL A 122
VAL A 100
None
1.17A 3gguA-3sokA:
undetectable
3gguA-3sokA:
24.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ss7 D-SERINE DEHYDRATASE

(Escherichia
coli)
PF00291
(PALP)
5 LEU X  22
GLY X 330
GLY X 343
PRO X 306
THR X 307
None
0.80A 3gguA-3ss7X:
undetectable
3gguA-3ss7X:
11.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ARG A   8
ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  50
SO4  A 101 (-3.8A)
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-4.0A)
017  A 201 (-3.3A)
0.68A 3gguA-3t3cA:
19.4
3gguA-3t3cA:
70.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
VAL A  84
SO4  A 101 (-4.2A)
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
None
0.46A 3gguA-3t3cA:
19.4
3gguA-3t3cA:
70.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
VAL A  84
SO4  A 101 (-4.2A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
None
None
0.64A 3gguA-3t3cA:
19.4
3gguA-3t3cA:
70.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
017  A 201 ( 4.8A)
None
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-3.0A)
1.33A 3gguA-3ttpA:
20.7
3gguA-3ttpA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
017  A 201 ( 4.8A)
None
017  A 201 (-2.6A)
017  A 201 (-3.6A)
017  A 201 (-3.4A)
017  A 201 (-4.6A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
017  A 201 (-4.1A)
0.32A 3gguA-3ttpA:
20.7
3gguA-3ttpA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
None
None
017  A 202 ( 2.5A)
017  A 201 (-3.4A)
017  A 201 (-3.2A)
017  A 202 (-2.9A)
1.46A 3gguA-3u7sA:
20.0
3gguA-3u7sA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
PRO A  81
VAL A  84
None
None
017  A 202 ( 2.5A)
017  A 201 ( 3.5A)
017  A 201 (-3.4A)
017  A 201 ( 4.0A)
017  A 202 (-2.9A)
017  A 202 (-4.0A)
None
0.43A 3gguA-3u7sA:
20.0
3gguA-3u7sA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
VAL A  84
None
017  A 202 ( 2.5A)
017  A 201 ( 3.5A)
017  A 201 (-3.4A)
017  A 201 ( 4.0A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
017  A 202 (-4.0A)
None
0.38A 3gguA-3u7sA:
20.0
3gguA-3u7sA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3uhl PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  84
None
0.25A 3gguA-3uhlA:
16.6
3gguA-3uhlA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3uhl PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 LEU A  23
GLY A  27
ALA A  28
PRO A  81
VAL A  84
None
0.50A 3gguA-3uhlA:
16.6
3gguA-3uhlA:
76.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3w03 DNA REPAIR PROTEIN
XRCC4


(Homo sapiens)
PF06632
(XRCC4)
5 LEU C 126
ALA C  42
GLY C  45
ILE C  34
VAL C 122
None
0.80A 3gguA-3w03C:
undetectable
3gguA-3w03C:
20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bgu MALATE DEHYDROGENASE

(Haloferax
volcanii)
PF00056
(Ldh_1_N)
PF02866
(Ldh_1_C)
5 GLY A  18
ALA A  17
GLY A   8
ILE A   7
VAL A 230
None
1.03A 3gguA-4bguA:
undetectable
3gguA-4bguA:
16.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dxy CYTOCHROME P450

(Novosphingobium
aromaticivorans)
PF00067
(p450)
5 LEU A 250
GLY A 365
ALA A 364
GLY A 357
THR A 101
HEM  A 501 (-4.3A)
HEM  A 501 (-3.4A)
HEM  A 501 ( 3.9A)
HEM  A 501 (-3.9A)
HEM  A 501 ( 4.8A)
0.96A 3gguA-4dxyA:
undetectable
3gguA-4dxyA:
14.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dzt AQUALYSIN-1

(Thermus
aquaticus)
PF00082
(Peptidase_S8)
5 LEU A  91
GLY A  30
VAL A 124
PRO A 226
VAL A  35
None
1.17A 3gguA-4dztA:
undetectable
3gguA-4dztA:
14.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ehc PE-PGRS FAMILY
PROTEIN


(Mycobacterium
tuberculosis)
no annotation 5 LEU A  34
ASP A  36
GLY A  38
VAL A  43
VAL A 115
None
ZN  A 301 (-2.3A)
ZN  A 301 ( 3.9A)
None
None
0.51A 3gguA-4ehcA:
7.8
3gguA-4ehcA:
16.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4k9q BENZOYLFORMATE
DECARBOXYLASE


(Polynucleobacter
necessarius)
PF00205
(TPP_enzyme_M)
PF02775
(TPP_enzyme_C)
PF02776
(TPP_enzyme_N)
5 ALA A 411
VAL A 368
GLY A  56
THR A 425
VAL A 423
None
1.00A 3gguA-4k9qA:
undetectable
3gguA-4k9qA:
11.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
RIT  A 500 (-2.4A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
1.26A 3gguA-4njvA:
19.9
3gguA-4njvA:
84.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
PRO A  81
THR A  82
None
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-4.8A)
None
RIT  A 500 (-3.9A)
RIT  A 500 (-3.5A)
0.58A 3gguA-4njvA:
19.9
3gguA-4njvA:
84.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  49
ILE A  50
PRO A  81
THR A  82
None
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
None
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.5A)
0.46A 3gguA-4njvA:
19.9
3gguA-4njvA:
84.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4oaq R-SPECIFIC CARBONYL
REDUCTASE


(Candida
parapsilosis)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 GLY A 162
ALA A 163
GLY A  75
THR A 360
VAL A 358
None
0.93A 3gguA-4oaqA:
undetectable
3gguA-4oaqA:
15.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rfs SUBSTRATE BINDING
PRITEIN S


(Lactobacillus
brevis)
PF12822
(ECF_trnsprt)
5 LEU S 190
GLY S 103
ALA S 102
GLY S  61
ILE S  60
None
1.19A 3gguA-4rfsS:
undetectable
3gguA-4rfsS:
18.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4um8 INTEGRIN ALPHA-V

(Homo sapiens)
PF01839
(FG-GAP)
PF08441
(Integrin_alpha2)
5 LEU A  57
ALA A 432
GLY A 428
PRO A  41
VAL A  38
None
1.03A 3gguA-4um8A:
undetectable
3gguA-4um8A:
9.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4x8y MEMBRANE-ASSOCIATED
PROGESTERONE
RECEPTOR COMPONENT 1


(Homo sapiens)
PF00173
(Cyt-b5)
5 LEU A 170
GLY A 118
ASP A  99
VAL A 167
VAL A  97
None
0.76A 3gguA-4x8yA:
undetectable
3gguA-4x8yA:
18.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
5 ARG A  10
LEU A  30
ASP A  32
GLY A  34
VAL A  39
None
None
4B1  A 201 (-2.9A)
4B1  A 201 ( 4.6A)
None
0.69A 3gguA-4ydfA:
13.0
3gguA-4ydfA:
32.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
6 LEU A  30
ASP A  32
GLY A  34
ALA A  35
VAL A  39
GLY A  58
None
4B1  A 201 (-2.9A)
4B1  A 201 ( 4.6A)
4B1  A 201 (-3.6A)
None
4B1  A 201 (-3.4A)
0.52A 3gguA-4ydfA:
13.0
3gguA-4ydfA:
32.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5b5q MEMBRANE THIOL
PROTEASE


(Chlamydia
trachomatis)
PF02902
(Peptidase_C48)
5 LEU B 188
ALA B 194
VAL B 279
ILE B 204
VAL B 244
None
1.12A 3gguA-5b5qB:
undetectable
3gguA-5b5qB:
17.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cfc VP1
VP3


(Cardiovirus B)
PF00073
(Rhv)
no annotation
5 LEU B 209
ALA A   5
ASP A   3
THR B 116
VAL B 114
None
0.82A 3gguA-5cfcB:
undetectable
3gguA-5cfcB:
17.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5chx XRCC4-MYH7-1590-1657

(Homo sapiens)
PF01576
(Myosin_tail_1)
PF06632
(XRCC4)
5 LEU A 126
ALA A  42
GLY A  45
ILE A  34
VAL A 122
None
0.79A 3gguA-5chxA:
undetectable
3gguA-5chxA:
19.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cj0 XRCC4-MYH7-(1631-169
2) CHIMERA PROTEIN


(Homo sapiens)
PF06632
(XRCC4)
5 LEU A 126
ALA A  42
GLY A  45
ILE A  34
VAL A 122
None
0.77A 3gguA-5cj0A:
undetectable
3gguA-5cj0A:
19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cj4 XRCC4-MYH7-(1562-162
2) CHIMERA PROTEIN


(Homo sapiens)
PF06632
(XRCC4)
5 LEU A 126
ALA A  42
GLY A  45
ILE A  34
VAL A 122
None
0.81A 3gguA-5cj4A:
undetectable
3gguA-5cj4A:
19.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5eco GLUTATHIONE
S-TRANSFERASE U20


(Arabidopsis
thaliana)
PF02798
(GST_N)
PF13410
(GST_C_2)
5 LEU B  68
GLY B  16
ALA B  19
VAL B  74
ILE B 158
None
1.13A 3gguA-5ecoB:
undetectable
3gguA-5ecoB:
14.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5fg3 PROBABLE TRANSLATION
INITIATION FACTOR
IF-2


(Aeropyrum
pernix)
PF00009
(GTP_EFTU)
PF03144
(GTP_EFTU_D2)
PF11987
(IF-2)
PF14578
(GTP_EFTU_D4)
5 GLY A 317
ALA A 316
GLY A 244
ILE A 334
VAL A 312
None
0.92A 3gguA-5fg3A:
undetectable
3gguA-5fg3A:
11.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5glj TYROSINE-PROTEIN
PHOSPHATASE
NON-RECEPTOR TYPE 13


(Homo sapiens)
PF00595
(PDZ)
5 LEU A1173
ALA A1167
VAL A1150
ILE A1161
VAL A1147
None
0.89A 3gguA-5gljA:
undetectable
3gguA-5gljA:
28.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gui CHAPERONE PROTEIN
CLPC1, CHLOROPLASTIC


(Arabidopsis
thaliana)
PF02861
(Clp_N)
5 LEU A 217
GLY A 211
VAL A 156
GLY A 122
VAL A 216
None
PO4  A 304 (-2.9A)
None
PO4  A 302 (-3.1A)
None
1.05A 3gguA-5guiA:
undetectable
3gguA-5guiA:
21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5l1t PENTALENOLACTONE
SYNTHASE


(Streptomyces
arenae)
PF00067
(p450)
5 LEU A 153
VAL A 148
GLY A 349
ILE A 348
VAL A 149
None
None
HEM  A 402 (-3.6A)
HEM  A 402 ( 4.1A)
None
1.08A 3gguA-5l1tA:
undetectable
3gguA-5l1tA:
13.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lhe N-(5'-PHOSPHORIBOSYL
)ANTHRANILATE
ISOMERASE


(Thermococcus
kodakarensis)
PF00697
(PRAI)
5 LEU A 160
GLY A 170
VAL A   5
GLY A 208
VAL A 181
None
1.04A 3gguA-5lheA:
undetectable
3gguA-5lheA:
21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mg5 HYDROXYMETHYLGLUTARY
L-COA SYNTHASE


(Pseudomonas
protegens)
no annotation 5 GLY A 162
ALA A 275
GLY A 283
ILE A 285
VAL A 272
None
1.04A 3gguA-5mg5A:
undetectable
3gguA-5mg5A:
19.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
None
1.16A 3gguA-5t2zA:
20.4
3gguA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
None
0.23A 3gguA-5t2zA:
20.4
3gguA-5t2zA:
79.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vat PENICILLIN-BINDING
PROTEIN ACTIVATOR
LPOA


(Haemophilus
influenzae)
PF04348
(LppC)
5 LEU A 261
GLY A 520
ALA A 523
GLY A 359
VAL A 317
None
1.12A 3gguA-5vatA:
undetectable
3gguA-5vatA:
11.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5x4l TRANSITIONAL
ENDOPLASMIC
RETICULUM ATPASE


(Homo sapiens)
PF02359
(CDC48_N)
PF02933
(CDC48_2)
5 ASP A 150
VAL A 116
ILE A 175
THR A 168
VAL A 165
None
1.14A 3gguA-5x4lA:
2.9
3gguA-5x4lA:
21.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5yt0 PROBABLE TRANSLATION
INITIATION FACTOR
IF-2


(Aeropyrum
pernix)
no annotation 5 GLY A 317
ALA A 316
GLY A 244
ILE A 334
VAL A 312
None
0.93A 3gguA-5yt0A:
undetectable
3gguA-5yt0A:
24.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5zhz PROBABLE
ENDONUCLEASE 4


(Mycobacterium
tuberculosis)
no annotation 5 GLY A 227
ALA A 228
ASP A 188
THR A 163
VAL A 190
None
0.95A 3gguA-5zhzA:
undetectable
3gguA-5zhzA:
20.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6c7s PUTATIVE RIFAMPIN
MONOOXYGENASE


(Nocardia
farcinica)
no annotation 5 GLY A 242
ALA A 241
VAL A 192
THR A 187
VAL A 191
None
0.86A 3gguA-6c7sA:
undetectable
3gguA-6c7sA:
19.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6f72 MTVAO615

(Thermothelomyces
thermophila)
no annotation 5 ARG A 262
LEU A 264
VAL A 289
THR A 258
VAL A 256
None
None
FAD  A 601 (-3.8A)
None
None
1.04A 3gguA-6f72A:
undetectable
3gguA-6f72A:
19.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fiv RETROPEPSIN

(Feline
immunodeficiency
virus)
PF00077
(RVP)
5 LEU A  28
ASP A  30
GLY A  32
ALA A  33
GLY A  58
None
3TL  A 201 (-3.5A)
3TL  A 201 (-3.4A)
3TL  A 201 (-4.0A)
3TL  A 201 (-3.4A)
0.13A 3gguA-6fivA:
15.8
3gguA-6fivA:
27.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6gbc MOLYBDOPTERIN
BIOSYNTHESIS PROTEIN
CNX1


(Arabidopsis
thaliana)
no annotation 5 LEU A 176
ALA A  54
ASP A 159
GLY A 153
VAL A 162
None
None
None
CSX  A 154 ( 2.4A)
None
1.18A 3gguA-6gbcA:
undetectable
3gguA-6gbcA:
undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
5 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  50
None
None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
0.88A 3gguA-6upjA:
18.7
3gguA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
7 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
PRO A  81
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
0.67A 3gguA-6upjA:
18.7
3gguA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
7 LEU A  23
ASP A  25
GLY A  27
ASP A  30
GLY A  49
ILE A  50
PRO A  81
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
0.78A 3gguA-6upjA:
18.7
3gguA-6upjA:
48.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1e19 CARBAMATE KINASE

(Pyrococcus
furiosus)
PF00696
(AA_kinase)
5 GLY A 219
ALA A 218
ASP A 214
GLY A  52
THR A 115
None
1.02A 3gguB-1e19A:
undetectable
3gguB-1e19A:
15.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  48
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 (-3.6A)
0.80A 3gguB-1hvcA:
13.2
3gguB-1hvcA:
39.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  48
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-4.1A)
0.80A 3gguB-1hvcA:
13.2
3gguB-1hvcA:
39.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
1.18A 3gguB-1hvcA:
13.2
3gguB-1hvcA:
39.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
1.20A 3gguB-1hvcA:
13.2
3gguB-1hvcA:
39.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
0.34A 3gguB-1hvcA:
13.2
3gguB-1hvcA:
39.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.7A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
0.37A 3gguB-1hvcA:
13.2
3gguB-1hvcA:
39.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jtd BETA-LACTAMASE
INHIBITOR PROTEIN II


(Streptomyces
exfoliatus)
PF13540
(RCC1_2)
5 LEU B 194
ASP B 187
ALA B 148
GLY B 111
THR B 192
None
CA  B 502 (-2.3A)
None
None
None
1.06A 3gguB-1jtdB:
undetectable
3gguB-1jtdB:
15.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1m64 FLAVOCYTOCHROME C3

(Shewanella
frigidimarina)
PF00890
(FAD_binding_2)
PF14537
(Cytochrom_c3_2)
5 GLY A 234
ALA A 244
GLY A 237
ILE A 399
THR A 377
None
None
None
None
FUM  A3001 (-3.7A)
0.99A 3gguB-1m64A:
undetectable
3gguB-1m64A:
10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1oi1 SCML2 PROTEIN

(Homo sapiens)
PF02820
(MBT)
5 ASP A 214
GLY A 211
ASP A 182
GLY A 241
THR A 193
None
1.07A 3gguB-1oi1A:
undetectable
3gguB-1oi1A:
16.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
5 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
None
0.40A 3gguB-1q9pA:
9.8
3gguB-1q9pA:
75.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
5 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
None
0.87A 3gguB-1sivA:
19.2
3gguB-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
6 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
THR A  80
None
1.29A 3gguB-1sivA:
19.2
3gguB-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
1.19A 3gguB-1sivA:
19.2
3gguB-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
None
0.32A 3gguB-1sivA:
19.2
3gguB-1sivA:
47.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tlg POLYANDROCARPA
LECTIN


(Polyandrocarpa
misakiensis)
PF00059
(Lectin_C)
5 LEU A  81
GLY A  56
ALA A  57
ASP A  58
GLY A  72
None
0.91A 3gguB-1tlgA:
undetectable
3gguB-1tlgA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tt4 PUTATIVE CYTOPLASMIC
PROTEIN


(Salmonella
enterica)
PF04107
(GCS2)
5 ALA A  72
ASP A  70
GLY A 255
ILE A 257
THR A  13
None
1.07A 3gguB-1tt4A:
undetectable
3gguB-1tt4A:
15.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vhc PUTATIVE KHG/KDPG
ALDOLASE


(Haemophilus
influenzae)
PF01081
(Aldolase)
5 LEU A  82
GLY A  87
ALA A  88
ASP A  89
ILE A  29
None
0.91A 3gguB-1vhcA:
undetectable
3gguB-1vhcA:
21.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xmp PHOSPHORIBOSYLAMINOI
MIDAZOLE CARBOXYLASE


(Bacillus
anthracis)
PF00731
(AIRC)
5 GLY A  66
ALA A  65
ASP A  14
GLY A 117
ILE A 116
None
1.07A 3gguB-1xmpA:
undetectable
3gguB-1xmpA:
18.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xrs D-LYSINE
5,6-AMINOMUTASE BETA
SUBUNIT


(Acetoanaerobium
sticklandii)
PF02310
(B12-binding)
PF16554
(OAM_dimer)
5 GLY B 238
ALA B 237
ASP B 236
ILE B 140
THR B 250
None
None
None
B12  B 800 (-4.8A)
None
1.00A 3gguB-1xrsB:
undetectable
3gguB-1xrsB:
18.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1y8c S-ADENOSYLMETHIONINE
-DEPENDENT
METHYLTRANSFERASE


(Clostridium
acetobutylicum)
PF13649
(Methyltransf_25)
5 LEU A  56
ASP A  40
ASP A  41
GLY A 137
THR A 107
None
1.03A 3gguB-1y8cA:
undetectable
3gguB-1y8cA:
15.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yb1 17-BETA-HYDROXYSTERO
ID DEHYDROGENASE
TYPE XI


(Homo sapiens)
PF00106
(adh_short)
5 GLY A 117
ALA A 116
GLY A  44
ILE A  43
THR A 164
None
CL  A 402 ( 4.1A)
None
SO4  A 702 (-3.8A)
None
1.04A 3gguB-1yb1A:
undetectable
3gguB-1yb1A:
19.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
6 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
0.19A 3gguB-2fmbA:
15.2
3gguB-2fmbA:
32.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
5 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  54
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
0.73A 3gguB-2fmbA:
15.2
3gguB-2fmbA:
32.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2h5z LYSOZYME 1

(Musca domestica)
PF00062
(Lys)
5 ALA A  80
ASP A  79
GLY A  52
ILE A  53
THR A  91
None
1.04A 3gguB-2h5zA:
undetectable
3gguB-2h5zA:
19.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2m1i PARVULIN-LIKE
PEPTIDYL-PROLYL
ISOMERASE


(Cenarchaeum
symbiosum)
PF13616
(Rotamase_3)
5 LEU A  16
ASP A  46
GLY A  48
ASP A  53
GLY A  57
None
0.98A 3gguB-2m1iA:
undetectable
3gguB-2m1iA:
24.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2oz8 MLL7089 PROTEIN

(Mesorhizobium
japonicum)
PF13378
(MR_MLE_C)
5 LEU A 219
ASP A 223
ASP A 194
GLY A 294
ILE A 293
None
0.99A 3gguB-2oz8A:
undetectable
3gguB-2oz8A:
15.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2q04 ACETOIN UTILIZATION
PROTEIN


(Exiguobacterium
sibiricum)
PF00583
(Acetyltransf_1)
5 LEU A 115
GLY A  22
ASP A 122
GLY A  60
ILE A  54
None
1.03A 3gguB-2q04A:
undetectable
3gguB-2q04A:
19.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2q2r GLUCOKINASE 1,
PUTATIVE


(Trypanosoma
cruzi)
PF02685
(Glucokinase)
5 LEU A 179
GLY A 188
ASP A 131
GLY A 306
ILE A 309
None
BGC  A1001 (-3.5A)
BGC  A1001 (-3.0A)
None
None
0.98A 3gguB-2q2rA:
undetectable
3gguB-2q2rA:
13.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qu7 PUTATIVE
TRANSCRIPTIONAL
REGULATOR


(Staphylococcus
saprophyticus)
PF13407
(Peripla_BP_4)
5 LEU A 259
GLY A 277
ALA A 249
GLY A 246
ILE A 274
None
1.05A 3gguB-2qu7A:
undetectable
3gguB-2qu7A:
18.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rgj FLAVIN-CONTAINING
MONOOXYGENASE


(Pseudomonas
aeruginosa)
PF01494
(FAD_binding_3)
5 LEU A 175
ALA A 311
ASP A 310
GLY A  11
ILE A   9
None
None
FAD  A 403 (-2.7A)
FAD  A 403 (-3.2A)
None
1.02A 3gguB-2rgjA:
undetectable
3gguB-2rgjA:
13.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
1.39A 3gguB-2rkfA:
19.9
3gguB-2rkfA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.8A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
0.37A 3gguB-2rkfA:
19.9
3gguB-2rkfA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rsp RSV PROTEASE

(Rous sarcoma
virus)
PF00077
(RVP)
5 LEU A  35
ASP A  37
GLY A  39
ALA A  40
ASP A  41
None
0.24A 3gguB-2rspA:
12.9
3gguB-2rspA:
30.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vn8 RETICULON-4-INTERACT
ING PROTEIN 1


(Homo sapiens)
PF08240
(ADH_N)
PF13602
(ADH_zinc_N_2)
5 LEU A 243
GLY A 248
ALA A 249
ASP A 250
ASP A 251
None
0.80A 3gguB-2vn8A:
undetectable
3gguB-2vn8A:
15.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vre DELTA(3,5)-DELTA(2,4
)-DIENOYL-COA
ISOMERASE


(Homo sapiens)
PF00378
(ECH_1)
5 LEU A 186
ALA A 178
ASP A 179
ILE A 146
THR A 154
None
0.98A 3gguB-2vreA:
undetectable
3gguB-2vreA:
16.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3a05 TRYPTOPHANYL-TRNA
SYNTHETASE


(Aeropyrum
pernix)
PF00579
(tRNA-synt_1b)
5 GLY A 215
ALA A 216
ASP A 219
GLY A  54
ILE A  52
None
1.06A 3gguB-3a05A:
undetectable
3gguB-3a05A:
11.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3a0f XYLOGLUCANASE

(Geotrichum sp.
M128)
no annotation 5 GLY A 119
ALA A 120
ASP A  34
GLY A 127
ILE A 177
None
1.06A 3gguB-3a0fA:
undetectable
3gguB-3a0fA:
8.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3c8t FUMARATE LYASE

(Chelativorans
sp. BNC1)
PF00206
(Lyase_1)
PF10397
(ADSL_C)
5 GLY A 341
ALA A 343
ASP A  27
GLY A 132
ILE A 129
None
0.97A 3gguB-3c8tA:
undetectable
3gguB-3c8tA:
11.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3eeq PUTATIVE COBALAMIN
BIOSYNTHESIS PROTEIN
G HOMOLOG


(Sulfolobus
solfataricus)
PF01890
(CbiG_C)
PF11760
(CbiG_N)
5 LEU A 318
GLY A 219
ALA A 306
GLY A 250
ILE A 249
None
0.96A 3gguB-3eeqA:
undetectable
3gguB-3eeqA:
20.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gf7 GLUTACONYL-COA
DECARBOXYLASE
SUBUNIT A


([Clostridium]
symbiosum)
PF01039
(Carboxyl_trans)
5 ALA A 405
ASP A 407
GLY A 363
ILE A 365
THR A 473
None
1.04A 3gguB-3gf7A:
undetectable
3gguB-3gf7A:
11.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gmi UPF0348 PROTEIN
MJ0951


(Methanocaldococcus
jannaschii)
PF05636
(HIGH_NTase1)
PF16581
(HIGH_NTase1_ass)
5 LEU A  62
GLY A 111
ALA A 112
ASP A 113
GLY A  73
None
0.86A 3gguB-3gmiA:
undetectable
3gguB-3gmiA:
15.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hgo 12-OXOPHYTODIENOATE
REDUCTASE 3


(Solanum
lycopersicum)
PF00724
(Oxidored_FMN)
5 GLY A 230
ALA A 231
ASP A 232
GLY A 235
ILE A 184
None
1.08A 3gguB-3hgoA:
undetectable
3gguB-3hgoA:
15.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i5g MYOSIN HEAVY CHAIN
ISOFORM A


(Doryteuthis
pealeii)
PF00063
(Myosin_head)
PF00612
(IQ)
PF02736
(Myosin_N)
5 GLY A 264
ALA A 265
ASP A 266
GLY A 460
ILE A 459
None
0.91A 3gguB-3i5gA:
undetectable
3gguB-3i5gA:
8.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jv7 ADH-A

(Rhodococcus
ruber)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 LEU A 211
GLY A 216
ALA A 217
ASP A 218
ILE A 190
None
0.66A 3gguB-3jv7A:
undetectable
3gguB-3jv7A:
14.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lp6 PHOSPHORIBOSYLAMINOI
MIDAZOLE CARBOXYLASE
CATALYTIC SUBUNIT


(Mycobacterium
tuberculosis)
PF00731
(AIRC)
5 GLY A  71
ALA A  70
ASP A  19
GLY A 122
ILE A 121
FMT  A 175 (-4.1A)
FMT  A 175 ( 4.3A)
FMT  A 175 (-3.5A)
None
None
1.02A 3gguB-3lp6A:
undetectable
3gguB-3lp6A:
18.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3m1r FORMIMIDOYLGLUTAMASE

(Bacillus
subtilis)
PF00491
(Arginase)
5 ASP A 289
GLY A  53
ALA A  54
GLY A  59
THR A 298
CL  A 321 ( 4.6A)
CL  A 321 ( 4.4A)
None
PEG  A 324 (-3.4A)
None
1.02A 3gguB-3m1rA:
undetectable
3gguB-3m1rA:
16.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  48
None
0.85A 3gguB-3mwsA:
20.1
3gguB-3mwsA:
69.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
1.23A 3gguB-3mwsA:
20.1
3gguB-3mwsA:
69.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
None
0.50A 3gguB-3mwsA:
20.1
3gguB-3mwsA:
69.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3opq PHOSPHORIBOSYLAMINOI
MIDAZOLE
CARBOXYLASE,CATALYTI
C SUBUNIT


(Francisella
tularensis)
PF00731
(AIRC)
5 GLY A  66
ALA A  65
ASP A  14
GLY A 117
ILE A 116
PO4  A 164 (-3.7A)
PO4  A 164 (-3.3A)
PO4  A 164 (-2.8A)
FMT  A 166 (-3.3A)
None
1.06A 3gguB-3opqA:
undetectable
3gguB-3opqA:
18.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ors N5-CARBOXYAMINOIMIDA
ZOLE RIBONUCLEOTIDE
MUTASE


(Staphylococcus
aureus)
PF00731
(AIRC)
5 GLY A  64
ALA A  63
ASP A  12
GLY A 115
ILE A 114
None
1.08A 3gguB-3orsA:
undetectable
3gguB-3orsA:
23.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rf7 IRON-CONTAINING
ALCOHOL
DEHYDROGENASE


(Shewanella
denitrificans)
PF00465
(Fe-ADH)
5 ASP A 104
GLY A 100
GLY A 137
ILE A 173
THR A 168
NAD  A 358 (-2.7A)
NAD  A 358 (-3.2A)
None
None
None
1.03A 3gguB-3rf7A:
undetectable
3gguB-3rf7A:
12.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slz GAG-PRO-POL
POLYPROTEIN


(Murine leukemia
virus)
PF00077
(RVP)
5 LEU A  30
ASP A  32
GLY A  34
ALA A  35
GLY A  56
None
3TL  A 126 (-2.4A)
3TL  A 126 (-3.1A)
3TL  A 126 ( 4.0A)
3TL  A 126 (-3.4A)
0.23A 3gguB-3slzA:
12.0
3gguB-3slzA:
25.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
SO4  A 101 (-4.2A)
017  A 201 (-2.6A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
017  A 201 (-4.0A)
017  A 201 (-3.3A)
1.29A 3gguB-3t3cA:
19.4
3gguB-3t3cA:
70.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
SO4  A 101 (-4.2A)
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
017  A 201 (-4.0A)
017  A 201 (-3.3A)
0.41A 3gguB-3t3cA:
19.4
3gguB-3t3cA:
70.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
None
017  A 201 (-2.6A)
017  A 201 (-3.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-4.6A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
0.32A 3gguB-3ttpA:
20.8
3gguB-3ttpA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
None
017  A 202 ( 2.5A)
017  A 201 (-3.4A)
017  A 201 ( 4.0A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
1.31A 3gguB-3u7sA:
20.0
3gguB-3u7sA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
None
017  A 202 ( 2.5A)
017  A 201 ( 3.5A)
017  A 201 (-3.4A)
017  A 201 (-3.2A)
017  A 201 ( 4.0A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
0.29A 3gguB-3u7sA:
20.0
3gguB-3u7sA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3uhl PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
None
0.27A 3gguB-3uhlA:
16.6
3gguB-3uhlA:
76.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3uxm THYMIDYLATE KINASE

(Pseudomonas
aeruginosa)
PF02223
(Thymidylate_kin)
5 GLY A 187
ALA A 186
ASP A 136
GLY A  13
THR A  18
None
0.94A 3gguB-3uxmA:
undetectable
3gguB-3uxmA:
19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3uxm THYMIDYLATE KINASE

(Pseudomonas
aeruginosa)
PF02223
(Thymidylate_kin)
5 GLY A 187
ALA A 186
ASP A 136
GLY A 142
THR A  18
None
1.03A 3gguB-3uxmA:
undetectable
3gguB-3uxmA:
19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3w9i MULTIDRUG RESISTANCE
PROTEIN MEXB


(Pseudomonas
aeruginosa)
PF00873
(ACR_tran)
5 LEU A 376
GLY A 403
ASP A 407
ASP A 408
THR A 379
LMT  A1101 ( 4.4A)
None
None
None
None
1.01A 3gguB-3w9iA:
undetectable
3gguB-3w9iA:
6.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3x0v L-LYSINE OXIDASE

(Trichoderma
viride)
PF01593
(Amino_oxidase)
5 GLY A 437
ALA A 438
GLY A  65
ILE A  64
THR A 370
None
FAD  A 601 (-3.7A)
FAD  A 601 (-4.1A)
None
None
0.96A 3gguB-3x0vA:
undetectable
3gguB-3x0vA:
10.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bo6 3-OXOACYL-[ACYL-CARR
IER-PROTEIN]
REDUCTASE FABG


(Pseudomonas
aeruginosa)
PF13561
(adh_short_C2)
5 LEU A 117
GLY A  91
ALA A  90
GLY A  18
ILE A  17
None
1.03A 3gguB-4bo6A:
undetectable
3gguB-4bo6A:
14.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dxy CYTOCHROME P450

(Novosphingobium
aromaticivorans)
PF00067
(p450)
5 LEU A 250
GLY A 365
ALA A 364
GLY A 357
THR A 101
HEM  A 501 (-4.3A)
HEM  A 501 (-3.4A)
HEM  A 501 ( 3.9A)
HEM  A 501 (-3.9A)
HEM  A 501 ( 4.8A)
0.97A 3gguB-4dxyA:
undetectable
3gguB-4dxyA:
14.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4e3a SUGAR KINASE PROTEIN

(Rhizobium etli)
PF00294
(PfkB)
5 LEU A   5
ALA A  59
ASP A 276
GLY A 155
THR A 151
None
None
ADN  A 500 (-2.8A)
None
None
1.07A 3gguB-4e3aA:
undetectable
3gguB-4e3aA:
12.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g1p CYS-GLY
METALLODIPEPTIDASE
DUG1


(Saccharomyces
cerevisiae)
PF01546
(Peptidase_M20)
PF07687
(M20_dimer)
5 LEU A 121
GLY A 140
ASP A 138
ASP A 137
GLY A 443
None
None
None
ZN  A 501 (-2.3A)
None
1.05A 3gguB-4g1pA:
undetectable
3gguB-4g1pA:
14.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gpc HEME OXYGENASE

(Corynebacterium
diphtheriae)
PF01126
(Heme_oxygenase)
5 LEU A  87
ASP A  86
GLY A 159
ASP A 154
ILE A 143
None
1.07A 3gguB-4gpcA:
undetectable
3gguB-4gpcA:
17.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4grd PHOSPHORIBOSYLAMINOI
MIDAZOLE CARBOXYLASE
CATALYTIC SUBUNIT


(Burkholderia
cenocepacia)
PF00731
(AIRC)
5 GLY A  77
ALA A  76
ASP A  25
GLY A 128
ILE A 127
None
1.05A 3gguB-4grdA:
undetectable
3gguB-4grdA:
20.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ida RIPENING-INDUCED
PROTEIN


(Fragaria vesca)
PF08240
(ADH_N)
PF13602
(ADH_zinc_N_2)
5 LEU A 203
GLY A 208
ALA A 209
ASP A 210
ILE A 179
None
0.90A 3gguB-4idaA:
undetectable
3gguB-4idaA:
15.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4igl YENB

(Yersinia
entomophaga)
PF03534
(SpvB)
PF12255
(TcdB_toxin_midC)
PF12256
(TcdB_toxin_midN)
5 GLY A 716
ALA A 717
ASP A 762
GLY A1362
ILE A  21
None
1.07A 3gguB-4iglA:
undetectable
3gguB-4iglA:
5.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4il5 CYSTEINE SYNTHASE

(Entamoeba
histolytica)
PF00291
(PALP)
5 LEU A  75
GLY A  97
ALA A  96
GLY A  90
ILE A 106
None
1.03A 3gguB-4il5A:
undetectable
3gguB-4il5A:
15.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kkm POLYPRENYL
SYNTHETASE


(Zymomonas
mobilis)
PF00348
(polyprenyl_synt)
5 ALA A 224
ASP A 225
ASP A 226
GLY A 218
ILE A 217
None
0.99A 3gguB-4kkmA:
undetectable
3gguB-4kkmA:
14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lgn CELLULOSE-BINDING,
FAMILY II


(Acidothermus
cellulolyticus)
no annotation 5 LEU A 304
GLY A 129
ASP A  21
GLY A 263
ILE A 242
None
1.04A 3gguB-4lgnA:
undetectable
3gguB-4lgnA:
7.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4maa PUTATIVE
BRANCHED-CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN


(Pseudomonas
protegens)
PF13458
(Peripla_BP_6)
5 LEU A 105
GLY A 128
ALA A 129
ASP A 130
GLY A 179
GOL  A 503 ( 4.4A)
GOL  A 503 (-3.7A)
None
None
None
0.94A 3gguB-4maaA:
undetectable
3gguB-4maaA:
14.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  48
RIT  A 500 (-2.4A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
RIT  A 500 (-4.8A)
0.83A 3gguB-4njvA:
19.9
3gguB-4njvA:
84.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
RIT  A 500 (-2.4A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
1.23A 3gguB-4njvA:
19.9
3gguB-4njvA:
84.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  82
None
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
RIT  A 500 (-3.5A)
0.58A 3gguB-4njvA:
19.9
3gguB-4njvA:
84.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rg8 EXONUCLEASE I

(Methylocaldum
szegediense)
PF00929
(RNase_T)
PF08411
(Exonuc_X-T_C)
5 GLY A  97
ASP A 104
GLY A  29
ILE A  30
THR A  93
None
MG  A 501 ( 4.1A)
None
None
None
1.05A 3gguB-4rg8A:
undetectable
3gguB-4rg8A:
13.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rlb CARBAPENEM-ASSOCIATE
D RESISTANCE PROTEIN


(Acinetobacter
baumannii)
no annotation 5 GLY A 196
ASP A 201
ASP A 123
GLY A 192
ILE A 188
None
1.07A 3gguB-4rlbA:
undetectable
3gguB-4rlbA:
16.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xky DIHYDRODIPICOLINATE
SYNTHASE


(Bacteroides
thetaiotaomicron)
PF00701
(DHDPS)
5 LEU A  94
GLY A  99
ALA A 100
ASP A 101
ILE A  69
None
None
None
MHO  A   1 ( 3.2A)
None
0.88A 3gguB-4xkyA:
undetectable
3gguB-4xkyA:
17.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
6 LEU A  30
ASP A  32
GLY A  34
ALA A  35
ASP A  36
GLY A  58
None
4B1  A 201 (-2.9A)
4B1  A 201 ( 4.6A)
4B1  A 201 (-3.6A)
4B1  A 201 (-4.4A)
4B1  A 201 (-3.4A)
0.31A 3gguB-4ydfA:
13.0
3gguB-4ydfA:
32.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5doo PROTEIN LYSINE
METHYLTRANSFERASE 2


(Rickettsia
typhi)
PF10119
(MethyTransf_Reg)
PF13847
(Methyltransf_31)
5 LEU A  75
ASP A  74
GLY A  53
ASP A  49
GLY A 119
None
1.09A 3gguB-5dooA:
undetectable
3gguB-5dooA:
12.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gle ISCHORISMATE LYASE

(Vibrio
anguillarum)
no annotation 5 LEU A  57
ALA A 176
ASP A 177
GLY A 172
ILE A 171
None
1.08A 3gguB-5gleA:
undetectable
3gguB-5gleA:
19.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gmx CARBOXYLESTERASE

(uncultured
bacterium)
PF00144
(Beta-lactamase)
5 GLY A 358
ALA A 351
ASP A 352
GLY A 285
THR A  79
None
1.08A 3gguB-5gmxA:
undetectable
3gguB-5gmxA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5h2v IMPORTIN SUBUNIT
BETA-3


(Saccharomyces
cerevisiae)
PF13513
(HEAT_EZ)
5 LEU A 909
GLY A 925
ALA A 970
ILE A 940
THR A 945
None
1.02A 3gguB-5h2vA:
undetectable
3gguB-5h2vA:
7.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5it1 PUTATIVE CYTOCHROME
P450


(Streptomyces
peucetius)
PF00067
(p450)
5 LEU A 278
GLY A 271
ALA A 273
GLY A 363
ILE A 360
None
1.04A 3gguB-5it1A:
undetectable
3gguB-5it1A:
13.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5k8c 3-DEOXY-ALPHA-D-MANN
O-OCTULOSONATE
8-OXIDASE


(Shewanella
oneidensis)
PF00465
(Fe-ADH)
5 ASP A 104
GLY A 100
GLY A 137
ILE A 173
THR A 168
NAD  A 401 (-2.8A)
NAD  A 401 (-3.3A)
None
None
None
1.03A 3gguB-5k8cA:
undetectable
3gguB-5k8cA:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ngy DSR-M GLUCANSUCRASE
INACTIVE MUTANT
E715Q


(Leuconostoc
citreum)
no annotation 5 GLY A1114
ALA A1119
ASP A1118
GLY A 631
THR A1130
None
1.05A 3gguB-5ngyA:
undetectable
3gguB-5ngyA:
5.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
1.21A 3gguB-5t2zA:
20.4
3gguB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
None
0.20A 3gguB-5t2zA:
20.4
3gguB-5t2zA:
79.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vol PUTATIVE ESTERASE

(Bacteroides
intestinalis)
PF00756
(Esterase)
5 LEU A  62
GLY A 155
ALA A 158
GLY A 112
THR A  99
None
1.07A 3gguB-5volA:
undetectable
3gguB-5volA:
17.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5x1n VANILLATE/3-O-METHYL
GALLATE
O-DEMETHYLASE


(Sphingobium sp.
SYK-6)
PF01571
(GCV_T)
PF08669
(GCV_T_C)
5 GLY A 168
ALA A 171
ASP A 173
GLY A 238
ILE A 240
None
1.05A 3gguB-5x1nA:
undetectable
3gguB-5x1nA:
12.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6ckv BCL-2-RELATED
OVARIAN KILLER
PROTEIN


(Homo sapiens)
no annotation 5 LEU A 133
ALA A 105
ASP A 104
GLY A 111
ILE A 113
None
1.09A 3gguB-6ckvA:
undetectable
3gguB-6ckvA:
22.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fiv RETROPEPSIN

(Feline
immunodeficiency
virus)
PF00077
(RVP)
6 LEU A  28
ASP A  30
GLY A  32
ALA A  33
ASP A  34
GLY A  58
None
3TL  A 201 (-3.5A)
3TL  A 201 (-3.4A)
3TL  A 201 (-4.0A)
3TL  A 201 (-3.9A)
3TL  A 201 (-3.4A)
0.14A 3gguB-6fivA:
15.8
3gguB-6fivA:
27.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6grw -

(-)
no annotation 5 LEU A 247
GLY A 277
ALA A 276
GLY A 265
ILE A 287
None
0.89A 3gguB-6grwA:
undetectable
3gguB-6grwA:
undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
5 LEU A  23
ASP A  25
ASP A  30
GLY A  49
ILE A  50
None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
1.03A 3gguB-6upjA:
18.7
3gguB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
7 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
0.68A 3gguB-6upjA:
18.7
3gguB-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
7 LEU A  23
ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
0.81A 3gguB-6upjA:
18.7
3gguB-6upjA:
48.48